ADARx Pharmaceuticals Inc. (ADRX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for ADARx Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$17.95
−0.99% today
Market cap
$1.9B
Overall quality
53/100
Kronos AI 30-day
—
ADARx Pharmaceuticals Inc. (ADRX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.9B. It trades at $17.95, down 0.99% today. Its overall quality score is 53 out of 100, ranked against the whole US market. 4 analysts' average target of $35.00 implies +95.0% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $35.00 |
| Low – high | $32.00 – $38.00 |
| Analysts | 4 |
| Upside to average | +95.0% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 30 |
| Solvency | 63 |
| Growth | 66 |
| Overall | 53 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.